Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
Australia
Skin & Cancer Foundation Australia - The Skin Hospital, Darlinghurst, New South Wales Novatrials, Kotara, New South Wales Cornerstone Dermatology, Coorparoo, Queensland New Zealand
Optimal Clinical Trials North, Auckland, Auckland Optimal Clinical Trials Central, Auckland, Auckland Momentum Pukehoke, Auckland, Auckland